Your browser doesn't support javascript.
Human inherited complete STAT2 deficiency underlies inflammatory viral diseases.
Bucciol, Giorgia; Moens, Leen; Ogishi, Masato; Rinchai, Darawan; Matuozzo, Daniela; Momenilandi, Mana; Kerrouche, Nacim; Cale, Catherine M; Treffeisen, Elsa R; Al Salamah, Mohammad; Al-Saud, Bandar K; Lachaux, Alain; Duclaux-Loras, Remi; Meignien, Marie; Bousfiha, Aziz; Benhsaien, Ibtihal; Shcherbina, Anna; Roppelt, Anna; Gothe, Florian; Houhou-Fidouh, Nadhira; Hackett, Scott J; Bartnikas, Lisa M; Maciag, Michelle C; Alosaimi, Mohammed F; Chou, Janet; Mohammed, Reem W; Freij, Bishara J; Jouanguy, Emmanuelle; Zhang, Shen-Ying; Boisson-Dupuis, Stephanie; Béziat, Vivien; Zhang, Qian; Duncan, Christopher Ja; Hambleton, Sophie; Casanova, Jean-Laurent; Meyts, Isabelle.
  • Bucciol G; Laboratory of Inborn Errors of Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Moens L; Department of Pediatrics, Leuven University Hospitals, Leuven, Belgium.
  • Ogishi M; Laboratory of Inborn Errors of Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Rinchai D; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA.
  • Matuozzo D; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA.
  • Momenilandi M; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • Kerrouche N; University of Paris Cité, Imagine Institute, Paris, France.
  • Cale CM; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • Treffeisen ER; University of Paris Cité, Imagine Institute, Paris, France.
  • Al Salamah M; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA.
  • Al-Saud BK; Department of Immunology, Great Ormond Street Hospital, London, United Kingdom.
  • Lachaux A; Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Duclaux-Loras R; King Abdullah Specialist Children's Hospital and International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.
  • Meignien M; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Bousfiha A; Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
  • Benhsaien I; Pediatric Department, Section of Immunology and Allergy, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Shcherbina A; Gastroenterology, Hepatology and Nutrition Unit, University and Pediatric Hospital of Lyon, and Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Autophagy, Infection and Immunity, Lyon, France.
  • Roppelt A; Gastroenterology, Hepatology and Nutrition Unit, University and Pediatric Hospital of Lyon, and Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Autophagy, Infection and Immunity, Lyon, France.
  • Gothe F; Clinical Immunology, Inflammation and Allergy Laboratory (LICIA), Faculty of Medicine and Pharmacy, King Hassan II University, Casablanca, Morocco.
  • Houhou-Fidouh N; Clinical Immunology Unit, Pediatric Infectious Disease Department Children's Hospital, Ibn Rochd University Hospital, Casablanca, Morocco.
  • Hackett SJ; Clinical Immunology, Inflammation and Allergy Laboratory (LICIA), Faculty of Medicine and Pharmacy, King Hassan II University, Casablanca, Morocco.
  • Bartnikas LM; Clinical Immunology Unit, Pediatric Infectious Disease Department Children's Hospital, Ibn Rochd University Hospital, Casablanca, Morocco.
  • Maciag MC; Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Alosaimi MF; Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Mohammed RW; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Freij BJ; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany.
  • Jouanguy E; Department of Virology, INSERM, Infection, Antimicrobiens, Modélisation, Evolution, UMR 1137, Bichat-Claude Bernard Hospital, University of Paris, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Zhang SY; Department of Paediatrics, Birmingham Chest Clinic and Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Boisson-Dupuis S; Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Béziat V; Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Zhang Q; Immunology Research Laboratory, Department of Pediatrics, King Saud University, Riyadh, Saudi Arabia.
  • Duncan CJ; Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Hambleton S; Pediatric Department, Section of Immunology and Allergy, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Casanova JL; Pediatric Infectious Diseases Section, Beaumont Children's Hospital, Royal Oak, Michigan, USA.
  • Meyts I; Oakland University William Beaumont School of Medicine, Rochester, Michigan, USA.
J Clin Invest ; 133(12)2023 06 15.
Article in English | MEDLINE | ID: covidwho-2253194
ABSTRACT
STAT2 is a transcription factor activated by type I and III IFNs. We report 23 patients with loss-of-function variants causing autosomal recessive (AR) complete STAT2 deficiency. Both cells transfected with mutant STAT2 alleles and the patients' cells displayed impaired expression of IFN-stimulated genes and impaired control of in vitro viral infections. Clinical manifestations from early childhood onward included severe adverse reaction to live attenuated viral vaccines (LAV) and severe viral infections, particularly critical influenza pneumonia, critical COVID-19 pneumonia, and herpes simplex virus type 1 (HSV-1) encephalitis. The patients displayed various types of hyperinflammation, often triggered by viral infection or after LAV administration, which probably attested to unresolved viral infection in the absence of STAT2-dependent types I and III IFN immunity. Transcriptomic analysis revealed that circulating monocytes, neutrophils, and CD8+ memory T cells contributed to this inflammation. Several patients died from viral infection or heart failure during a febrile illness with no identified etiology. Notably, the highest mortality occurred during early childhood. These findings show that AR complete STAT2 deficiency underlay severe viral diseases and substantially impacts survival.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / Virus Diseases / Encephalitis, Herpes Simplex / Influenza, Human / COVID-19 Type of study: Etiology study / Prognostic study Topics: Vaccines / Variants Limits: Child, preschool / Humans Language: English Year: 2023 Document Type: Article Affiliation country: JCI168321

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / Virus Diseases / Encephalitis, Herpes Simplex / Influenza, Human / COVID-19 Type of study: Etiology study / Prognostic study Topics: Vaccines / Variants Limits: Child, preschool / Humans Language: English Year: 2023 Document Type: Article Affiliation country: JCI168321